LII · NYSE · STOCK
Lennox International (LII) Stock Analysis
$356.56
52W $350.22 – $587.27
58/100
$12.32B
16.1
1.16
Is LII Bullish or Bearish?
Mixed.
Innellis AI committee rates Lennox International (LII) Watch with a composite score of 58/100
, based on 5 analysts with 40% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +2.46 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -17.54 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.43 across 7 articles, 14d). Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 67.0% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
- News sentiment is positive (+0.43 across 7 articles, 14d) — News
Bear Case
- Price-to-book of 14.6x prices in significant intangible value — Value
- Revenue declining -2.1% YoY -- this is not a growth story right now — Growth
- EPS declining -3.0% YoY despite any revenue growth — Growth
- Price structure making lower highs and lower lows — Technical
- Weekly RSI at 25 -- oversold on the larger timeframe too — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
58/100
Agreement
40%
Analysts
5
Conviction
Contested
Sector Rank
Top 48%
of 227 Industrials peers
Value Analyst
neutral
55
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 67.0% shows genuine earnings power backing the valuation
− Price-to-book of 14.6x prices in significant intangible value
Growth Analyst
bearish
40
/ 100 · High confidence
Growth story is weak, decelerating, or inconsistent
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− Revenue declining -2.1% YoY -- this is not a growth story right now
Technical Analyst
neutral
56
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
71
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.43 across 7 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 56.9 to 57.5.
- New bearish signals: 1 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
Analyst-level changes:
- News Analyst: score 68->71 (+3); +1 bullish signal(s).
- Technical Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
40.3
Neutral
MACD Histogram
2.075
Bullish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Mixed
Bollinger %B
0.20
Inside Bands
Price vs Moving Averages
EMA 9
$360.89
Below
EMA 21
$367.25
Below
EMA 50
$395.89
Below
EMA 200
$468.98
Below
Fundamental Analysis
Valuation
65
Growth
64
Profitability
76
Financial Health
56
Cash Flow
70
Valuation
P/E Ratio
16.1×
P/B Ratio
9.53×
PEG Ratio
-2.84
Dividend Yield
1.49%
52W High
$587.27
52W Low
$350.22
Quality & Growth
ROE
6928.0%
ROA
1974.1%
Gross Margin
3310.1%
Operating Margin
1937.1%
Revenue Growth YoY
—
Debt / Equity
1.56
AI Fundamental Assessment
P/E ratio of 16.1 (inexpensive relative to a 15-40x range); Price-to-book of 9.5x; PEG ratio of -2.8 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 69.3%; Return on assets of 19.7%; Net margin of 14.6%; Gross margin of 33.1%; Current ratio of 1.57 (healthy short-term liquidity); Debt-to-equity of 1.56; Free cash flow per share is positive (21.29); Most recent quarter missed estimates by 0.5%; EPS growth accelerating (-24.7% -> +130.4% QoQ); Average YoY EPS growth of -1.3%; Analyst estimates rising over recent quarters
Get the Full LII Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →